Skip to main content
Premium Trial:

Request an Annual Quote

Jochen Kohlhaas, Gerald Mller, Michael Kranich, Christof Hettich, Michael Meyer, and Expression Analysis


People in the News

Jochen Kohlhaas has become vice president for finance of Febit Biotech, the Heidelberg, Germany-based firm said last week. He holds a degree in business administration.

Febit also has named Gerald Möller, Michael Kranich, Christof Hettich, and Michael Meyer to serve as members on its new supervisory board.

Möller, a former president and CEO of the Boehringer Mannheim Group and a former member of Roche's executive board, will serve as president of Febit's advisory board.

Michael Kranich will serve as a representative of Febit core investors Dietmar Hopp and Oliver Hopp. Kranich is also the CEO of German venture capital firms DH Capital and OG Beteiligungen.

Hettich, of Rittershaus Mannheim, currently serves as Febit's law advisor, and Meyer is CEO of Technostart, another VC firm that has invested in Febit.


New Product Watch

Expression Analysis has concluded an upgrade of its laboratory systems to support new Affymetrix products, the company said last week.

According to EA, the upgrade includes the addition of Affymetrix 7G and MegAllele scanners, which in turn enable the array service provider to run Affy's Exon Arrays, 500K Mapping Array Set and the MegAllele DME-T assay developed by ParAllele Biosciences.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.